Eterna Therapeutics Inc
ERNA1.330USD
+0.060+4.72%
종가 09/19, 16:00（ET）시세는 15분 지연됩니다
9.95M시가총액
손실P/E TTM
자세한 내용은 Eterna Therapeutics Inc 회사
Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.
회사 정보
종목 코드 ERNA
회사 이름Ernexa Therapeutics Inc
상장일Aug 29, 1991
CEOMr. Sanjeev Luther
직원 수6
유형Ordinary Share
회계 연도 종료Aug 29
주소1035 Cambridge Street
도시CAMBRIDGE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호02141
전화16177986700
웹사이트https://www.ernexatx.com/
종목 코드 ERNA
상장일Aug 29, 1991
CEOMr. Sanjeev Luther
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. James Bristol
Dr. James Bristol
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sanjeev Luther
Mr. Sanjeev Luther
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Sandra Gurrola
Ms. Sandra Gurrola
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Mr. Peter Cicala
Mr. Peter Cicala
Independent Director
Independent Director
--
--
Dr. Elena Ratner
Dr. Elena Ratner
Independent Director
Independent Director
--
--
Mr. William Wexler
Mr. William Wexler
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. James Bristol
Dr. James Bristol
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sanjeev Luther
Mr. Sanjeev Luther
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Sandra Gurrola
Ms. Sandra Gurrola
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Mr. Peter Cicala
Mr. Peter Cicala
Independent Director
Independent Director
--
--
Dr. Elena Ratner
Dr. Elena Ratner
Independent Director
Independent Director
--
--
Mr. William Wexler
Mr. William Wexler
Independent Director
Independent Director
--
--
수익 분석
통화: USD마지막 업데이트: Mon, Feb 24
통화: USD마지막 업데이트: Mon, Feb 24
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Subscription revenue
4.88M
84.17%
Other revenue
492.00K
8.48%
Hardware revenue
426.00K
7.34%
지역별USD
이름
수익
비율
United States
5.48M
94.48%
Canada
320.00K
5.52%
사업별
지역별
사업별USD
이름
수익
비율
Subscription revenue
4.88M
84.17%
Other revenue
492.00K
8.48%
Hardware revenue
426.00K
7.34%
주식 보유 통계
마지막 업데이트: Fri, Aug 29
마지막 업데이트: Fri, Aug 29
주주
주주 유형
주주
주주
비율
Cherington (Charles)
36.21%
Freebird Partners LP
5.40%
Halpern (John D)
5.09%
Denny George P Iii
4.34%
IAF, LLC
4.12%
기타
44.85%
주주
주주
비율
Cherington (Charles)
36.21%
Freebird Partners LP
5.40%
Halpern (John D)
5.09%
Denny George P Iii
4.34%
IAF, LLC
4.12%
기타
44.85%
주주 유형
주주
비율
Individual Investor
46.42%
Corporation
13.29%
Investment Advisor/Hedge Fund
0.49%
Investment Advisor
0.15%
기타
39.65%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
52
4.57M
62.10%
+1.55M
2025Q1
56
2.92M
80.53%
+838.33K
2024Q4
54
33.02M
64.27%
+30.12M
2024Q3
67
2.84M
52.46%
-257.40K
2024Q2
83
2.52M
46.53%
-624.19K
2024Q1
121
2.54M
46.88%
-584.16K
2023Q4
126
2.36M
43.79%
-543.57K
2023Q3
142
2.77M
52.76%
-391.46K
2023Q2
146
2.77M
53.56%
-376.86K
2023Q1
150
2.98M
67.03%
+101.08K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cherington (Charles)
2.78M
37.73%
+1.42M
+104.20%
Jun 09, 2025
Freebird Partners LP
414.10K
5.63%
--
--
Apr 14, 2025
Halpern (John D)
390.45K
5.3%
--
--
Apr 14, 2025
Denny George P Iii
332.71K
4.52%
+3.36K
+1.02%
Apr 14, 2025
IAF, LLC
217.03K
2.95%
--
--
Apr 14, 2025
Regolith Capital Investments LP
222.88K
3.03%
--
--
Apr 14, 2025
Purchase Capital LLC
66.67K
0.91%
+66.67K
--
Dec 31, 2024
Singer (Nicholas Jason)
54.00K
0.73%
+54.00K
--
Dec 31, 2024
Geode Capital Management, L.L.C.
19.54K
0.27%
+2.39K
+13.93%
Mar 31, 2025
Corient Private Wealth LLC
17.52K
0.24%
--
--
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Oct 12, 2022
Merger
20→1
Oct 12, 2022
Merger
20→1
Oct 12, 2022
Merger
20→1
Oct 12, 2022
Merger
20→1
Mar 24, 2021
Merger
2→1
Mar 24, 2021
Merger
2→1
날짜
유형
비율
Oct 12, 2022
Merger
20→1
Oct 12, 2022
Merger
20→1
Oct 12, 2022
Merger
20→1
Oct 12, 2022
Merger
20→1
Mar 24, 2021
Merger
2→1
Mar 24, 2021
Merger
2→1
Mar 24, 2021
Merger
2→1
Mar 24, 2021
Merger
2→1
